Skip to content

Study · Non-randomized trial · n = 36 · 1998

2 results

[Effects of cerebrolysin on the oxidant homeostasis, the content of microelements and electrolytes in children with minimal brain dysfunction].

Gromova OA, Avdeenko TV, Burtsev EM, Skal'nyĭ AV, Solov'ev OI

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 1998Cited by 2 (Europe PMC)

PMID9505400 (opens in a new tab)PepBankPUB-09505400
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In children with minimal cerebral dysfunction, Cerebrolysin had a reported positive influence on clinical manifestations and oxidant and element homeostasis.

    In plain wordsIn children with minimal cerebral dysfunction, symptoms and oxidant and element balance showed reported benefits after Cerebrolysin.

    Peptide
    Cerebrolysin
    Outcome
    Direction not reportedClinical manifestations and oxidant and element homeostasis
    Study

    n = 36

    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    2-5 ml · intramuscular · 1 monthAs given in this study (human).

    Source sentences

    Summary
    There was observed positive influence of the drug on the clinical manifestations of the disease, oxidant and elements homeostasis.
    2 context sentences
    Summary · context
    In 36 children of 3-8 years old with minimal cerebral dysfunction there were evaluated both concentrations of malonic dialdehyde in blood plasma, erythrocytes and platelets as well as the content of 25 elements (K, Mg, Ca, Na, P, Se, Zn, Co, Cr, Cu, Fe, Mn, Mo, Si, Li, Ni, V, Pb, Sn, Cd, Al, As, Be, Bi, Ti) in hairs.
    Summary · context
    These indices were estimated both before and after course of cerebrolysin therapy (the a dose 2-5 ml intramuscularly during 1 month).

Studies that did not test the peptide alone1

In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cerebrolysin.

  1. 02LabNot a test of Cerebrolysin aloneIn vitro (cell-free)Other

    In nuclear-emission analysis, Cerebrolysin contained relatively high amounts of magnesium, potassium, phosphorus, and selenium.

    In plain wordsIn lab tests, Cerebrolysin contained relatively high amounts of magnesium, potassium, phosphorus, and selenium.

    Peptide
    Cerebrolysin
    Outcome
    Not applicableElemental composition
    Study

    n: not reported in source

    Nuclear-emission analysis of Cerebrolysin
    Outcome group
    Product quality and purity · Pharmacology

    Source sentences

    Summary
    Nuclear-emission analysis of the elements' composition of cerebrolysin revealed quite high content in the drug of magnesium, potassium, phosphorus, and selenium which had neuroactive and antioxidant properties.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.